These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Is serum creatinine a reliable expression of an adequate cyclosporine immunosuppression? Cantarovich F; Cantarovich D; Suso E; Lefrançois N; Touraine JL; Traeger J Clin Nephrol; 1988 Jan; 29(1):9-11. PubMed ID: 3289807 [TBL] [Abstract][Full Text] [Related]
7. Prospective controlled trial of steroid withdrawal after six months in renal transplant patients treated with cyclosporine. Maiorca R; Cristinelli L; Brunori G; Setti G; Salerni B; De Nobili U; Mittempergher F Transplant Proc; 1988 Jun; 20(3 Suppl 3):121-5. PubMed ID: 3291224 [No Abstract] [Full Text] [Related]
8. Changes in the pharmacokinetics of cyclosporine and three of its metabolites in renal transplant patients early in the posttransplant period. Awni WM; Kasiske B; Heim-Duthoy K; Rose M; Rao VK; Bloom P; Ney A; Andrisevic J; Odland M; Andersen RC Transplant Proc; 1988 Apr; 20(2 Suppl 2):623-4. PubMed ID: 3284111 [No Abstract] [Full Text] [Related]
9. Cyclosporine impairs the renal response to volume depletion. Laskow DA; Curtis J; Luke R; Jones P; Barber H; Deierhoi M; Diethelm A Transplant Proc; 1988 Jun; 20(3 Suppl 3):568-71. PubMed ID: 3291293 [No Abstract] [Full Text] [Related]
10. Antithymocyte gamma globulin, low-dosage cyclosporine, and tapering steroids as an immunosuppressive regimen to avoid early kidney failure in heart transplantation. Deeb GM; Kolff J; McClurken JB; Dunn J; Balsara R; Ochs R; Badellino M; Hollander T; Eldridge C; Clancey M J Heart Transplant; 1987; 6(2):79-83. PubMed ID: 3305833 [TBL] [Abstract][Full Text] [Related]
11. Different pharmacokinetics of cyclosporine A early and late after renal transplantation. Wilms HW; Straeten V; Lison AE Transplant Proc; 1988 Apr; 20(2 Suppl 2):481-4. PubMed ID: 3284093 [No Abstract] [Full Text] [Related]
13. Combination therapy of cyclosporine and azathioprine in living-related kidney transplant recipients compared with patients converted totally from cyclosporine to azathioprine. Oka T; Omori Y; Aikawa I; Yasumura T; Yoshimura N; Nakai I Transplant Proc; 1988 Jun; 20(3 Suppl 3):143-6. PubMed ID: 3291229 [No Abstract] [Full Text] [Related]
14. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral. Ritschel WA Clin Transplant; 1996 Aug; 10(4):364-73. PubMed ID: 8884110 [TBL] [Abstract][Full Text] [Related]
15. Experience with clinical use of Sandimmun Neoral in renal transplant patients. Min ZL; Zhao M; Zhu YH; Qi J; Wang LM; Wang YW Transplant Proc; 1996 Jun; 28(3):1356-7. PubMed ID: 8658692 [No Abstract] [Full Text] [Related]
16. C2 monitoring of cyclosporine in stable renal transplant patients results in lower costs and improved renal function. Domínguez J; Fuenzalida D; Norambuena R; Pais E; Cortes Monroy G; Llanos R Transplant Proc; 2005 Apr; 37(3):1583-5. PubMed ID: 15866680 [TBL] [Abstract][Full Text] [Related]
17. The cyclosporine-sparing effects of diltiazem in renal transplantation. McCauley J; Ptachcinski RJ; Shapiro R Transplant Proc; 1989 Dec; 21(6):3955-7. PubMed ID: 2609415 [No Abstract] [Full Text] [Related]
18. Ocular bioavailability of cyclosporine after oral administration. Tabbara KF; Gee SS; Alvarez H Transplant Proc; 1988 Apr; 20(2 Suppl 2):656-9. PubMed ID: 3363663 [No Abstract] [Full Text] [Related]
19. Influence of biliary T tube clamping on cyclosporine pharmacokinetics in liver transplant recipients. Tredger JM; Naoumov NV; Steward CM; O'Grady JG; Grevel J; Niven AA; Kelman AW; Whiting B; Williams R Transplant Proc; 1988 Apr; 20(2 Suppl 2):512-5. PubMed ID: 3284098 [No Abstract] [Full Text] [Related]
20. An update on the use of low-dose maintenance cyclosporine A therapy after renal transplantation. Karmi SA; DePalma R; Bosch J; Dosa S; Michell A Transplant Proc; 1988 Jun; 20(3 Suppl 3):110-3. PubMed ID: 3291218 [No Abstract] [Full Text] [Related] [Next] [New Search]